 | • レポートコード：QFJ1-5122 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、細胞治療＆組織工学の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（細胞治療、組織工学）、用途別市場規模（細胞欠陥、遺伝病、神経変性疾患、組織悪性腫瘍、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・細胞治療＆組織工学の市場動向 ・企業の競争状況、市場シェア ・細胞治療＆組織工学の種類別市場規模と予測2016-2027（細胞治療、組織工学） ・細胞治療＆組織工学の用途別市場規模と予測2016-2027（細胞欠陥、遺伝病、神経変性疾患、組織悪性腫瘍、その他） ・細胞治療＆組織工学の北米市場規模2016-2027（アメリカ、カナダ） ・細胞治療＆組織工学の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・細胞治療＆組織工学のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・細胞治療＆組織工学の中南米市場規模2016-2027（メキシコ、ブラジル） ・細胞治療＆組織工学の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Betalin Therapeutics、BioCardia, Inc、BioReliance Corporation、Biosolution Co.、Brainstorm Cell Therapeutics, Inc、MaxCyte, Inc、Medigene AG、MEDIPOST CO.、Mesoblast Limited、Miromatrix Medical, Inc.、MolMed S.p.A、Mustang Bio, Inc、NantKwest, Inc.、Neuralstem, Inc、NexImmune, Inc.、Nohla Therapeutics, Inc、ReNeuron Group plc、Richter-Helm BioLogics GmbH & Co. KG、RoosterBio, Inc、RoslinCT、Rubius Therapeutics, Inc.、Sangamo Therapeutics, Inc、Voyager Therapeutics, Inc、Waisman Biomanufacturing、WindMIL Therapeutics, Inc.、Wuxi App Tec, Inc.、ReNeuron Group plc、Richter-Helm BioLogics GmbH & Co. KG、RoosterBio, Inc、RoslinCT） ・結論 |
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.
Market Analysis and Insights: Global Cell Therapy and Tissue Engineering Market
The global Cell Therapy and Tissue Engineering market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell Therapy and Tissue Engineering market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell Therapy and Tissue Engineering market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell Therapy and Tissue Engineering market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell Therapy and Tissue Engineering market.
Global Cell Therapy and Tissue Engineering Scope and Market Size
Cell Therapy and Tissue Engineering market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell Therapy and Tissue Engineering market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cell Therapy
Tissue Engineering
Segment by Application
Cell Defects
Genetic Diseases
Neurodegenerative Diseases
Tissue Malignancies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Betalin Therapeutics
BioCardia, Inc
BioReliance Corporation
Biosolution Co.
Brainstorm Cell Therapeutics, Inc
MaxCyte, Inc
Medigene AG
MEDIPOST CO.
Mesoblast Limited
Miromatrix Medical, Inc.
MolMed S.p.A
Mustang Bio, Inc
NantKwest, Inc.
Neuralstem, Inc
NexImmune, Inc.
Nohla Therapeutics, Inc
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Rubius Therapeutics, Inc.
Sangamo Therapeutics, Inc
Voyager Therapeutics, Inc
Waisman Biomanufacturing
WindMIL Therapeutics, Inc.
Wuxi App Tec, Inc.
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.3 Market by Application
1.3.1 Global Cell Therapy and Tissue Engineering Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cell Defects
1.3.3 Genetic Diseases
1.3.4 Neurodegenerative Diseases
1.3.5 Tissue Malignancies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy and Tissue Engineering Market Perspective (2016-2027)
2.2 Cell Therapy and Tissue Engineering Growth Trends by Regions
2.2.1 Cell Therapy and Tissue Engineering Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cell Therapy and Tissue Engineering Historic Market Share by Regions (2016-2021)
2.2.3 Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2022-2027)
2.3 Cell Therapy and Tissue Engineering Industry Dynamic
2.3.1 Cell Therapy and Tissue Engineering Market Trends
2.3.2 Cell Therapy and Tissue Engineering Market Drivers
2.3.3 Cell Therapy and Tissue Engineering Market Challenges
2.3.4 Cell Therapy and Tissue Engineering Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy and Tissue Engineering Players by Revenue
3.1.1 Global Top Cell Therapy and Tissue Engineering Players by Revenue (2016-2021)
3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Players (2016-2021)
3.2 Global Cell Therapy and Tissue Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy and Tissue Engineering Revenue
3.4 Global Cell Therapy and Tissue Engineering Market Concentration Ratio
3.4.1 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy and Tissue Engineering Revenue in 2020
3.5 Cell Therapy and Tissue Engineering Key Players Head office and Area Served
3.6 Key Players Cell Therapy and Tissue Engineering Product Solution and Service
3.7 Date of Enter into Cell Therapy and Tissue Engineering Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy and Tissue Engineering Breakdown Data by Type
4.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Type (2016-2021)
4.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2022-2027)
5 Cell Therapy and Tissue Engineering Breakdown Data by Application
5.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Application (2016-2021)
5.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cell Therapy and Tissue Engineering Market Size (2016-2027)
6.2 North America Cell Therapy and Tissue Engineering Market Size by Type
6.2.1 North America Cell Therapy and Tissue Engineering Market Size by Type (2016-2021)
6.2.2 North America Cell Therapy and Tissue Engineering Market Size by Type (2022-2027)
6.2.3 North America Cell Therapy and Tissue Engineering Market Size by Type (2016-2027)
6.3 North America Cell Therapy and Tissue Engineering Market Size by Application
6.3.1 North America Cell Therapy and Tissue Engineering Market Size by Application (2016-2021)
6.3.2 North America Cell Therapy and Tissue Engineering Market Size by Application (2022-2027)
6.3.3 North America Cell Therapy and Tissue Engineering Market Size by Application (2016-2027)
6.4 North America Cell Therapy and Tissue Engineering Market Size by Country
6.4.1 North America Cell Therapy and Tissue Engineering Market Size by Country (2016-2021)
6.4.2 North America Cell Therapy and Tissue Engineering Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cell Therapy and Tissue Engineering Market Size (2016-2027)
7.2 Europe Cell Therapy and Tissue Engineering Market Size by Type
7.2.1 Europe Cell Therapy and Tissue Engineering Market Size by Type (2016-2021)
7.2.2 Europe Cell Therapy and Tissue Engineering Market Size by Type (2022-2027)
7.2.3 Europe Cell Therapy and Tissue Engineering Market Size by Type (2016-2027)
7.3 Europe Cell Therapy and Tissue Engineering Market Size by Application
7.3.1 Europe Cell Therapy and Tissue Engineering Market Size by Application (2016-2021)
7.3.2 Europe Cell Therapy and Tissue Engineering Market Size by Application (2022-2027)
7.3.3 Europe Cell Therapy and Tissue Engineering Market Size by Application (2016-2027)
7.4 Europe Cell Therapy and Tissue Engineering Market Size by Country
7.4.1 Europe Cell Therapy and Tissue Engineering Market Size by Country (2016-2021)
7.4.2 Europe Cell Therapy and Tissue Engineering Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy and Tissue Engineering Market Size (2016-2027)
8.2 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Type
8.2.1 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Type (2016-2027)
8.3 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Application
8.3.1 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Application (2016-2027)
8.4 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Region
8.4.1 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell Therapy and Tissue Engineering Market Size (2016-2027)
9.2 Latin America Cell Therapy and Tissue Engineering Market Size by Type
9.2.1 Latin America Cell Therapy and Tissue Engineering Market Size by Type (2016-2021)
9.2.2 Latin America Cell Therapy and Tissue Engineering Market Size by Type (2022-2027)
9.2.3 Latin America Cell Therapy and Tissue Engineering Market Size by Type (2016-2027)
9.3 Latin America Cell Therapy and Tissue Engineering Market Size by Application
9.3.1 Latin America Cell Therapy and Tissue Engineering Market Size by Application (2016-2021)
9.3.2 Latin America Cell Therapy and Tissue Engineering Market Size by Application (2022-2027)
9.3.3 Latin America Cell Therapy and Tissue Engineering Market Size by Application (2016-2027)
9.4 Latin America Cell Therapy and Tissue Engineering Market Size by Country
9.4.1 Latin America Cell Therapy and Tissue Engineering Market Size by Country (2016-2021)
9.4.2 Latin America Cell Therapy and Tissue Engineering Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy and Tissue Engineering Market Size (2016-2027)
10.2 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type
10.2.1 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type (2016-2027)
10.3 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application
10.3.1 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application (2016-2027)
10.4 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Country
10.4.1 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Betalin Therapeutics
11.1.1 Betalin Therapeutics Company Details
11.1.2 Betalin Therapeutics Business Overview
11.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Introduction
11.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.1.5 Betalin Therapeutics Recent Development
11.2 BioCardia, Inc
11.2.1 BioCardia, Inc Company Details
11.2.2 BioCardia, Inc Business Overview
11.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Introduction
11.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.2.5 BioCardia, Inc Recent Development
11.3 BioReliance Corporation
11.3.1 BioReliance Corporation Company Details
11.3.2 BioReliance Corporation Business Overview
11.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Introduction
11.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.3.5 BioReliance Corporation Recent Development
11.4 Biosolution Co.
11.4.1 Biosolution Co. Company Details
11.4.2 Biosolution Co. Business Overview
11.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Introduction
11.4.4 Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.4.5 Biosolution Co. Recent Development
11.5 Brainstorm Cell Therapeutics, Inc
11.5.1 Brainstorm Cell Therapeutics, Inc Company Details
11.5.2 Brainstorm Cell Therapeutics, Inc Business Overview
11.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.5.5 Brainstorm Cell Therapeutics, Inc Recent Development
11.6 MaxCyte, Inc
11.6.1 MaxCyte, Inc Company Details
11.6.2 MaxCyte, Inc Business Overview
11.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Introduction
11.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.6.5 MaxCyte, Inc Recent Development
11.7 Medigene AG
11.7.1 Medigene AG Company Details
11.7.2 Medigene AG Business Overview
11.7.3 Medigene AG Cell Therapy and Tissue Engineering Introduction
11.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.7.5 Medigene AG Recent Development
11.8 MEDIPOST CO.
11.8.1 MEDIPOST CO. Company Details
11.8.2 MEDIPOST CO. Business Overview
11.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Introduction
11.8.4 MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.8.5 MEDIPOST CO. Recent Development
11.9 Mesoblast Limited
11.9.1 Mesoblast Limited Company Details
11.9.2 Mesoblast Limited Business Overview
11.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Introduction
11.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.9.5 Mesoblast Limited Recent Development
11.10 Miromatrix Medical, Inc.
11.10.1 Miromatrix Medical, Inc. Company Details
11.10.2 Miromatrix Medical, Inc. Business Overview
11.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Introduction
11.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.10.5 Miromatrix Medical, Inc. Recent Development
11.11 MolMed S.p.A
11.11.1 MolMed S.p.A Company Details
11.11.2 MolMed S.p.A Business Overview
11.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Introduction
11.11.4 MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.11.5 MolMed S.p.A Recent Development
11.12 Mustang Bio, Inc
11.12.1 Mustang Bio, Inc Company Details
11.12.2 Mustang Bio, Inc Business Overview
11.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Introduction
11.12.4 Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.12.5 Mustang Bio, Inc Recent Development
11.13 NantKwest, Inc.
11.13.1 NantKwest, Inc. Company Details
11.13.2 NantKwest, Inc. Business Overview
11.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Introduction
11.13.4 NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.13.5 NantKwest, Inc. Recent Development
11.14 Neuralstem, Inc
11.14.1 Neuralstem, Inc Company Details
11.14.2 Neuralstem, Inc Business Overview
11.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Introduction
11.14.4 Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.14.5 Neuralstem, Inc Recent Development
11.15 NexImmune, Inc.
11.15.1 NexImmune, Inc. Company Details
11.15.2 NexImmune, Inc. Business Overview
11.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Introduction
11.15.4 NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.15.5 NexImmune, Inc. Recent Development
11.16 Nohla Therapeutics, Inc
11.16.1 Nohla Therapeutics, Inc Company Details
11.16.2 Nohla Therapeutics, Inc Business Overview
11.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.16.4 Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.16.5 Nohla Therapeutics, Inc Recent Development
11.17 ReNeuron Group plc
11.17.1 ReNeuron Group plc Company Details
11.17.2 ReNeuron Group plc Business Overview
11.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
11.17.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.17.5 ReNeuron Group plc Recent Development
11.18 Richter-Helm BioLogics GmbH & Co. KG
11.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Details
11.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
11.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
11.18.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.18.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development
11.18 RoosterBio, Inc
11.25.1 RoosterBio, Inc Company Details
11.25.2 RoosterBio, Inc Business Overview
11.25.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
11.25.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.25.5 RoosterBio, Inc Recent Development
11.20 RoslinCT
11.20.1 RoslinCT Company Details
11.20.2 RoslinCT Business Overview
11.20.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
11.20.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.20.5 RoslinCT Recent Development
11.21 Rubius Therapeutics, Inc.
11.21.1 Rubius Therapeutics, Inc. Company Details
11.21.2 Rubius Therapeutics, Inc. Business Overview
11.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
11.21.4 Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.21.5 Rubius Therapeutics, Inc. Recent Development
11.22 Sangamo Therapeutics, Inc
11.22.1 Sangamo Therapeutics, Inc Company Details
11.22.2 Sangamo Therapeutics, Inc Business Overview
11.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.22.4 Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.22.5 Sangamo Therapeutics, Inc Recent Development
11.23 Voyager Therapeutics, Inc
11.23.1 Voyager Therapeutics, Inc Company Details
11.23.2 Voyager Therapeutics, Inc Business Overview
11.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.23.4 Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.23.5 Voyager Therapeutics, Inc Recent Development
11.24 Waisman Biomanufacturing
11.24.1 Waisman Biomanufacturing Company Details
11.24.2 Waisman Biomanufacturing Business Overview
11.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Introduction
11.24.4 Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.24.5 Waisman Biomanufacturing Recent Development
11.25 WindMIL Therapeutics, Inc.
11.25.1 WindMIL Therapeutics, Inc. Company Details
11.25.2 WindMIL Therapeutics, Inc. Business Overview
11.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
11.25.4 WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.25.5 WindMIL Therapeutics, Inc. Recent Development
11.26 Wuxi App Tec, Inc.
11.26.1 Wuxi App Tec, Inc. Company Details
11.26.2 Wuxi App Tec, Inc. Business Overview
11.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Introduction
11.26.4 Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.26.5 Wuxi App Tec, Inc. Recent Development
11.27 ReNeuron Group plc
11.27.1 ReNeuron Group plc Company Details
11.27.2 ReNeuron Group plc Business Overview
11.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
11.27.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.27.5 ReNeuron Group plc Recent Development
11.28 Richter-Helm BioLogics GmbH & Co. KG
11.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Details
11.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
11.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
11.28.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.28.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development
11.29 RoosterBio, Inc
11.29.1 RoosterBio, Inc Company Details
11.29.2 RoosterBio, Inc Business Overview
11.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
11.29.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.29.5 RoosterBio, Inc Recent Development
11.30 RoslinCT
11.30.1 RoslinCT Company Details
11.30.2 RoslinCT Business Overview
11.30.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
11.30.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2016-2021)
11.30.5 RoslinCT Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Tissue Engineering
Table 4. Global Cell Therapy and Tissue Engineering Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cell Therapy and Tissue Engineering Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cell Therapy and Tissue Engineering Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cell Therapy and Tissue Engineering Market Share by Regions (2016-2021)
Table 8. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cell Therapy and Tissue Engineering Market Share by Regions (2022-2027)
Table 10. Cell Therapy and Tissue Engineering Market Trends
Table 11. Cell Therapy and Tissue Engineering Market Drivers
Table 12. Cell Therapy and Tissue Engineering Market Challenges
Table 13. Cell Therapy and Tissue Engineering Market Restraints
Table 14. Global Cell Therapy and Tissue Engineering Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cell Therapy and Tissue Engineering Market Share by Players (2016-2021)
Table 16. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2020)
Table 17. Ranking of Global Top Cell Therapy and Tissue Engineering Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cell Therapy and Tissue Engineering Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cell Therapy and Tissue Engineering Product Solution and Service
Table 21. Date of Enter into Cell Therapy and Tissue Engineering Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2016-2021)
Table 25. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cell Therapy and Tissue Engineering Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cell Therapy and Tissue Engineering Revenue Market Share by Application (2016-2021)
Table 29. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cell Therapy and Tissue Engineering Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cell Therapy and Tissue Engineering Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cell Therapy and Tissue Engineering Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cell Therapy and Tissue Engineering Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cell Therapy and Tissue Engineering Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cell Therapy and Tissue Engineering Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cell Therapy and Tissue Engineering Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Country (2022-2027) & (US$ Million)
Table 61. Betalin Therapeutics Company Details
Table 62. Betalin Therapeutics Business Overview
Table 63. Betalin Therapeutics Cell Therapy and Tissue Engineering Product
Table 64. Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 65. Betalin Therapeutics Recent Development
Table 66. BioCardia, Inc Company Details
Table 67. BioCardia, Inc Business Overview
Table 68. BioCardia, Inc Cell Therapy and Tissue Engineering Product
Table 69. BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 70. BioCardia, Inc Recent Development
Table 71. BioReliance Corporation Company Details
Table 72. BioReliance Corporation Business Overview
Table 73. BioReliance Corporation Cell Therapy and Tissue Engineering Product
Table 74. BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 75. BioReliance Corporation Recent Development
Table 76. Biosolution Co. Company Details
Table 77. Biosolution Co. Business Overview
Table 78. Biosolution Co. Cell Therapy and Tissue Engineering Product
Table 79. Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 80. Biosolution Co. Recent Development
Table 81. Brainstorm Cell Therapeutics, Inc Company Details
Table 82. Brainstorm Cell Therapeutics, Inc Business Overview
Table 83. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product
Table 84. Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 85. Brainstorm Cell Therapeutics, Inc Recent Development
Table 86. MaxCyte, Inc Company Details
Table 87. MaxCyte, Inc Business Overview
Table 88. MaxCyte, Inc Cell Therapy and Tissue Engineering Product
Table 89. MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 90. MaxCyte, Inc Recent Development
Table 91. Medigene AG Company Details
Table 92. Medigene AG Business Overview
Table 93. Medigene AG Cell Therapy and Tissue Engineering Product
Table 94. Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 95. Medigene AG Recent Development
Table 96. MEDIPOST CO. Company Details
Table 97. MEDIPOST CO. Business Overview
Table 98. MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 99. MEDIPOST CO. Recent Development
Table 100. Mesoblast Limited Company Details
Table 101. Mesoblast Limited Business Overview
Table 102. Mesoblast Limited Cell Therapy and Tissue Engineering Product
Table 103. Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 104. Mesoblast Limited Recent Development
Table 105. Miromatrix Medical, Inc. Company Details
Table 106. Miromatrix Medical, Inc. Business Overview
Table 107. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product
Table 108. Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 109. Miromatrix Medical, Inc. Recent Development
Table 110. MolMed S.p.A Company Details
Table 111. MolMed S.p.A Business Overview
Table 112. MolMed S.p.A Cell Therapy and Tissue Engineering Product
Table 113. MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 114. MolMed S.p.A Recent Development
Table 115. Mustang Bio, Inc Company Details
Table 116. Mustang Bio, Inc Business Overview
Table 117. Mustang Bio, Inc Cell Therapy and Tissue Engineering Product
Table 118. Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 119. Mustang Bio, Inc Recent Development
Table 120. NantKwest, Inc. Company Details
Table 121. NantKwest, Inc. Business Overview
Table 122. NantKwest, Inc. Cell Therapy and Tissue Engineering Product
Table 123. NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 124. NantKwest, Inc. Recent Development
Table 125. Neuralstem, Inc Company Details
Table 126. Neuralstem, Inc Business Overview
Table 127. Neuralstem, Inc Cell Therapy and Tissue Engineering Product
Table 128. Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 129. Neuralstem, Inc Recent Development
Table 130. NexImmune, Inc. Company Details
Table 131. NexImmune, Inc. Business Overview
Table 132. NexImmune, Inc. Cell Therapy and Tissue Engineering Product
Table 133. NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 134. NexImmune, Inc. Recent Development
Table 135. Nohla Therapeutics, Inc Company Details
Table 136. Nohla Therapeutics, Inc Business Overview
Table 137. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product
Table 138. Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 139. Nohla Therapeutics, Inc Recent Development
Table 140. ReNeuron Group plc Company Details
Table 141. ReNeuron Group plc Business Overview
Table 142. ReNeuron Group plc Cell Therapy and Tissue Engineering Product
Table 143. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 144. ReNeuron Group plc Recent Development
Table 145. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 146. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 147. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product
Table 148. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 149. Richter-Helm BioLogics GmbH & Co. KG Recent Development
Table 150. RoosterBio, Inc Company Details
Table 151. RoosterBio, Inc Business Overview
Table 152. RoosterBio, Inc Cell Therapy and Tissue Engineering Product
Table 153. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 154. RoosterBio, Inc Recent Development
Table 155. RoslinCT Company Details
Table 156. RoslinCT Business Overview
Table 157. RoslinCT Cell Therapy and Tissue Engineering Product
Table 158. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 159. RoslinCT Recent Development
Table 160. Rubius Therapeutics, Inc. Company Details
Table 161. Rubius Therapeutics, Inc. Business Overview
Table 162. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product
Table 163. Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 164. Rubius Therapeutics, Inc. Recent Development
Table 165. Sangamo Therapeutics, Inc Company Details
Table 166. Sangamo Therapeutics, Inc Business Overview
Table 167. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product
Table 168. Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 169. Sangamo Therapeutics, Inc Recent Development
Table 170. Voyager Therapeutics, Inc Company Details
Table 171. Voyager Therapeutics, Inc Business Overview
Table 172. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product
Table 173. Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 174. Voyager Therapeutics, Inc Recent Development
Table 175. Waisman Biomanufacturing Company Details
Table 176. Waisman Biomanufacturing Business Overview
Table 177. Waisman Biomanufacturing Cell Therapy and Tissue EngineeringProduct
Table 178. Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 179. Waisman Biomanufacturing Recent Development
Table 180. WindMIL Therapeutics, Inc. Company Details
Table 181. WindMIL Therapeutics, Inc. Business Overview
Table 182. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product
Table 183. WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 184. WindMIL Therapeutics, Inc. Recent Development
Table 185. Wuxi App Tec, Inc. Company Details
Table 186. Wuxi App Tec, Inc. Business Overview
Table 187. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product
Table 188. Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 189. Wuxi App Tec, Inc. Recent Development
Table 190. ReNeuron Group plc Company Details
Table 191. ReNeuron Group plc Business Overview
Table 192. ReNeuron Group plc Cell Therapy and Tissue Engineering Product
Table 193. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 194. ReNeuron Group plc Recent Development
Table 195. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 196. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 197. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product
Table 198. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 199. Richter-Helm BioLogics GmbH & Co. KG Recent Development
Table 200. RoosterBio, Inc Company Details
Table 201. RoosterBio, Inc Business Overview
Table 202. RoosterBio, Inc Cell Therapy and Tissue Engineering Product
Table 203. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 204. RoosterBio, Inc Recent Development
Table 205. RoslinCT Company Details
Table 206. RoslinCT Business Overview
Table 207. RoslinCT Cell Therapy and Tissue Engineering Product
Table 208. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million)
Table 209. RoslinCT Recent Development
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Therapy and Tissue Engineering Market Share by Type: 2020 VS 2027
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Global Cell Therapy and Tissue Engineering Market Share by Application: 2020 VS 2027
Figure 5. Cell Defects Case Studies
Figure 6. Genetic Diseases Case Studies
Figure 7. Neurodegenerative Diseases Case Studies
Figure 8. Tissue Malignancies Case Studies
Figure 9. Others Case Studies
Figure 10. Cell Therapy and Tissue Engineering Report Years Considered
Figure 11. Global Cell Therapy and Tissue Engineering Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cell Therapy and Tissue Engineering Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cell Therapy and Tissue Engineering Market Share by Regions: 2020 VS 2027
Figure 14. Global Cell Therapy and Tissue Engineering Market Share by Regions (2022-2027)
Figure 15. Global Cell Therapy and Tissue Engineering Market Share by Players in 2020
Figure 16. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2020
Figure 18. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2016-2021)
Figure 19. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2022-2027)
Figure 20. North America Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cell Therapy and Tissue Engineering Market Share by Type (2016-2027)
Figure 22. North America Cell Therapy and Tissue Engineering Market Share by Application (2016-2027)
Figure 23. North America Cell Therapy and Tissue Engineering Market Share by Country (2016-2027)
Figure 24. United States Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cell Therapy and Tissue Engineering Market Share by Type (2016-2027)
Figure 28. Europe Cell Therapy and Tissue Engineering Market Share by Application (2016-2027)
Figure 29. Europe Cell Therapy and Tissue Engineering Market Share by Country (2016-2027)
Figure 30. Germany Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cell Therapy and Tissue Engineering Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cell Therapy and Tissue Engineering Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cell Therapy and Tissue Engineering Market Share by Region (2016-2027)
Figure 40. China Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cell Therapy and Tissue Engineering Market Share by Type (2016-2027)
Figure 48. Latin America Cell Therapy and Tissue Engineering Market Share by Application (2016-2027)
Figure 49. Latin America Cell Therapy and Tissue Engineering Market Share by Country (2016-2027)
Figure 50. Mexico Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cell Therapy and Tissue Engineering Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cell Therapy and Tissue Engineering Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cell Therapy and Tissue Engineering Market Share by Country (2016-2027)
Figure 56. Turkey Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Betalin Therapeutics Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 60. BioCardia, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 61. BioReliance Corporation Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 62. Biosolution Co. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 63. Brainstorm Cell Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 64. MaxCyte, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 65. Medigene AG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 66. MEDIPOST CO. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 67. Mesoblast Limited Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 68. Miromatrix Medical, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 69. MolMed S.p.A Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 70. Mustang Bio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 71. NantKwest, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 72. Neuralstem, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 73. NexImmune, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 74. Nohla Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 75. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 76. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 77. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 78. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 79. Rubius Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 80. Sangamo Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 81. Voyager Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 82. Waisman Biomanufacturing Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 83. WindMIL Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 84. Wuxi App Tec, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 85. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 86. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 87. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 88. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
世界の組織再生エンジニアリング市場規模・現状・予測（2021年-2027年） Tissue Regeneration Engineering is a combination of cellular, engineering and materials methods and appropriate biochemical and physical and chemical factors to improve or replace biological tissue. Tissue Regeneration Engineering is to obtain a small amount of living tissue from the body, use speci…- 組織エンジニアリングのグローバル市場2021 Tissue Engineering is a process involving in-vitro development of tissues or organs. It is done to replace or support the function of defective or injured body part. Tissue engineering involves the application of biology and engineering for innovation of tissue substitutes that can maintain, restore…
- 世界の自己細胞療法市場規模・現状・予測（2021年-2027年） Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is t…
- 世界の個別化細胞療法市場規模・現状・予測（2021年-2027年） The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physio…
- 世界の胎盤幹細胞療法市場規模・現状・予測（2021年-2027年） Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regene…